CompletedNCT04943796
This study is completed in Canada, in the United Kingdom, in Switzerland, .... It focuses on ADHD.
Multiple locations, including BurnabyADHDOtherOver 18 Years
- Countries
- Canada, United Kingdom, Switzerland, ...
- Sponsor
- Takeda
- Condition
- ADHD
CompletedNCT05278104
This study is completed in Germany. It focuses on ADHD.
Multiple locations, including AachenADHDDrugA study involving a medication or substance.From 18 Years to 45 Years
- Countries
- Germany
- Sponsor
- Boehringer Ingelheim
- Condition
- ADHD
CompletedNCT00475735
This study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalADHDDrugFrom 18 Years to 55 Years
- Countries
- Global
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- ADHD
CompletedNCT05588713
This study is completed. It focuses on ADHD and currently lists study information in Sweden.
In UppsalaADHDOtherFrom 8 Years to 17 Years
- Countries
- Sweden
- Sponsor
- Uppsala University
- Condition
- ADHD
CompletedNCT02255513
This study is completed in the United States. It is testing HLD200 for ADHD.
Multiple locations, including Newport BeachADHDDrugFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Condition
- ADHD
CompletedNCT03605680
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In New YorkADHDDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT03605849
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In Culver CityADHDDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT05257265
This study is completed in the United States. It focuses on ADHD.
In New YorkADHDDrugFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT05428033
This study is completed in the United States. It focuses on ADHD.
In New YorkADHDDrugFrom 4 Years to 12 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT05279313
This study is completed. It focuses on ADHD and currently lists study information in Canada and the United States.
Multiple locations, including DothanADHDDrugFrom 4 Years to 18 Years
- Countries
- United States, Canada
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
Active Not RecruitingNCT05102864
This study is active but not recruiting. It focuses on ADHD and currently lists study information in the United States.
In East ProvidenceADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 18 Years
- Countries
- United States
- Sponsor
- Bradley Hospital
- Condition
- ADHD
CompletedNCT07314333
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In Salt Lake CityADHDDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
